Matthias Mehling
Matthias Mehling
Unknown affiliation
Verified email at
Cited by
Cited by
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M Mehling, V Brinkmann, J Antel, A Bar-Or, N Goebels, C Vedrine, ...
Neurology 71 (16), 1261-1267, 2008
Lack of association between antimyelin antibodies and progression to multiple sclerosis
J Kuhle, C Pohl, M Mehling, G Edan, MS Freedman, HP Hartung, ...
New England Journal of Medicine 356 (4), 371-378, 2007
Microfluidic cell culture
M Mehling, S Tay
Current opinion in Biotechnology 25, 95-102, 2014
A PD‐1 polymorphism is associated with disease progression in multiple sclerosis
A Kroner, M Mehling, B Hemmer, P Rieckmann, KV Toyka, M Mäurer, ...
Annals of neurology 58 (1), 50-57, 2005
Altered expression of miR‐17‐5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients
RLP Lindberg, F Hoffmann, M Mehling, J Kuhle, L Kappos
European journal of immunology 40 (3), 888-898, 2010
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
M Mehling, R Lindberg, F Raulf, J Kuhle, C Hess, L Kappos, V Brinkmann
Neurology 75 (5), 403-410, 2010
Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis
J Kuhle, RLP Lindberg, A Regeniter, M Mehling, AJ Steck, L Kappos, ...
European journal of neurology 16 (6), 771-774, 2009
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
M Mehling, TA Johnson, J Antel, L Kappos, A Bar-Or
Neurology 76 (8 Supplement 3), S20-S27, 2011
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J Kuhle, D Leppert, A Petzold, A Regeniter, C Schindler, M Mehling, ...
Neurology 76 (14), 1206-1213, 2011
A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein
J Kuhle, A Regeniter, D Leppert, M Mehling, L Kappos, RLP Lindberg, ...
Journal of neuroimmunology 220 (1-2), 114-119, 2010
Antigen‐specific adaptive immune responses in fingolimod‐treated multiple sclerosis patients
M Mehling, P Hilbert, S Fritz, B Durovic, D Eichin, O Gasser, J Kuhle, ...
Annals of neurology 69 (2), 408-413, 2011
Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions
M Mehling, L Kappos, T Derfuss
Current neurology and neuroscience reports 11 (5), 492, 2011
WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
M Mehling, P Simon, M Mittelbronn, R Meyermann, S Ferrone, M Weller, ...
Acta neuropathologica 114 (2), 111-119, 2007
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF
J Kuhle, RLP Lindberg, A Regeniter, M Mehling, F Hoffmann, M Reindl, ...
Journal of neurology 254 (2), 160-168, 2007
A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting
A Regeniter, J Kuhle, M Mehling, H Möller, U Wurster, H Freidank, ...
Clinical neurology and neurosurgery 111 (4), 313-318, 2009
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis
L Kappos, M Mehling, R Arroyo, G Izquierdo, K Selmaj, V Curovic-Perisic, ...
Neurology 84 (9), 872-879, 2015
The immune-metabolic basis of effector memory CD4+ T cell function under hypoxic conditions
S Dimeloe, M Mehling, C Frick, J Loeliger, GR Bantug, U Sauder, ...
The Journal of Immunology 196 (1), 106-114, 2016
A microfluidic device for measuring cell migration towards substrate-bound and soluble chemokine gradients
J Schwarz, V Bierbaum, J Merrin, T Frank, R Hauschild, T Bollenbach, ...
Scientific reports 6, 36440, 2016
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, ...
Multiple Sclerosis Journal 20 (5), 577-587, 2014
Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis
H Gensicke, D Leppert, O Yaldizli, RLP Lindberg, M Mehling, L Kappos, ...
CNS drugs 26 (1), 11-37, 2012
The system can't perform the operation now. Try again later.
Articles 1–20